Neuro-Oncology Reviews

Volume 25 Number 10
31 May 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 10, 31 May

Guerin JB, Kaufmann TJ, Eckel LJ, Morris JM, Vaubel RA, Giannini C, Johnson DR.
A Radiologist's Guide to the 2021 WHO Central Nervous System Tumor Classification: Part 2-Newly Described and Revised Tumor Types.
Radiology. 2023 May 16:221885. doi: 10.1148/radiol.221885. PMID: 37191486. Review˰ ˍ

Titov O, Bykanov A, Pitskhelauri D.
Neurosurgical skills analysis by machine learning models: systematic review.
Neurosurg Rev. 2023 May 16;46(1):121. doi: 10.1007/s10143-023-02028-x. PMID: 37191734. Review˰ ˍ

Zaghloul MS, Hunter A, Mostafa AG, Parkes J.
Re-irradiation for recurrent/progressive pediatric brain tumors: from radiobiology to clinical outcomes.
Expert Rev Anticancer Ther. 2023 May 16:1-9. doi: 10.1080/14737140.2023.2215439. PMID: 37194207. Review˰ ˍ

Andrews LJ, Davies P, Herbert C, Kurian KM.
Pre-diagnostic blood biomarkers for adult glioma.
Front Oncol. 2023 May 17;13:1163289. doi: 10.3389/fonc.2023.1163289. PMID: 37265788. Review. ˍ

Shahabifard H, Zarei M, Kookli K, Esmalian Afyouni N, Soltani N, Maghsoodi S, Adili A, Mahmoudi J, Shomali N, Sandoghchian Shotorbani S.
An updated overview of the application of CAR-T cell therapy in neurological diseases.
Biotechnol Prog. 2023 May 17:e3356. doi: 10.1002/btpr.3356. PMID: 37198722. Review˰ ˍ

Agosti E, Panciani PP, Zeppieri M, De Maria L, Pasqualetti F, Tel A, Zanin L, Fontanella MM, Ius T.
Tumor Microenvironment and Glioblastoma Cell Interplay as Promoters of Therapeutic Resistance.
Biology (Basel). 2023 May 18;12(5):736. doi: 10.3390/biology12050736. PMID: 37237548. Review. ˍ

Baroni LV, Fernández Ponce N, Freytes C, Maldonado FR, Pinto N, González Ramos J, Lubieniecki F, Zubizarreta P, Alderete D.
Closing the gap: National Argentinian discussion forum on paediatric brain tumours.
Front Oncol. 2023 May 18;13:1185766. doi: 10.3389/fonc.2023.1185766. PMID: 37274284. Meeting report. ˍ

Ek H, Fagerström Kristensen I, Stenberg L, Kinhult S, Benedek H, Ek S, Engelholm SA, Engelholm S, Munck Af Rosenschöld P.
Transitioning from conventional photon therapy to proton therapy for primary brain tumors.
Acta Oncol. 2023 May 18:1-9. doi: 10.1080/0284186X.2023.2200150. PMID: 37203198. Review. ˍ

Gillette JS, Wang EJ, Dowd RS, Toms SA.
Barriers to overcoming immunotherapy resistance in glioblastoma.
Front Med (Lausanne). 2023 May 18;10:1175507. doi: 10.3389/fmed.2023.1175507. PMID: 37275361. Review. ˍ

Martin KC, Ma C, Yip S.
From Theory to Practice: Implementing the WHO 2021 Classification of Adult Diffuse Gliomas in Neuropathology Diagnosis.
Brain Sci. 2023 May 18;13(5):817. doi: 10.3390/brainsci13050817. PMID: 37239289. Review. ˍ

Di Filippo LD, de Carvalho SG, Duarte JL, Luiz MT, Paes Dutra JA, de Paula GA, Chorilli M, Conde J.
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas.
Mater Today Bio. 2023 May 19;20:100671. doi: 10.1016/j.mtbio.2023.100671. PMID: 37273792. Review. ˍ

Duerinck J, Tuyaerts S, Movahedi K, Neyns B.
Overcoming the immune suppressive nature of glioblastoma by leveraging the surgical intervention - current status and future perspectives.
Front Immunol. 2023 May 19;14:1183641. doi: 10.3389/fimmu.2023.1183641. PMID: 37275902. Review. ˍ

Embring A, Blomstrand M, Asklid A, Nilsson MP, Agrup M, Svärd AM, Fröjd C, Martinsson U, Fagerström Kristensen I, Engellau J.
Re-irradiation in Paediatric Tumours of the Central Nervous System: National Guidelines from the Swedish Workgroup of Paediatric Radiotherapy.
Clin Oncol (R Coll Radiol). 2023 May 19:S0936-6555(23)00185-1. doi: 10.1016/j.clon.2023.05.007. PMID: 37246041. Guidelines˰ ˍ

Rafii S, Kandoussi S, Ghouzlani A, Naji O, Reddy KP, Ullah Sadiqi R, Badou A.
Deciphering immune microenvironment and cell evasion mechanisms in human gliomas.
Front Oncol. 2023 May 19;13:1135430. doi: 10.3389/fonc.2023.1135430. PMID: 37274252. Review. ˍ

Wan S, Zhang G, Liu R, Abbas MN, Cui H.
Pyroptosis, ferroptosis, and autophagy cross-talk in glioblastoma opens up new avenues for glioblastoma treatment.
Cell Commun Signal. 2023 May 19;21(1):115. doi: 10.1186/s12964-023-01108-1. PMID: 37208730. Review. ˍ


Yuile A, Wei JQ, Mohan AA, Hotchkiss KM, Khasraw M.
Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas.
Cancers (Basel). 2023 May 21;15(10):2856. doi: 10.3390/cancers15102856. PMID: 37345193. Review. ˍ

Baisiwala S, Ko M, Zubair H, Li K, Vivas AC, Everson R, Liau L, Bari A, Patel KS.
Metastatic secondary gliosarcoma: patient series.
J Neurosurg Case Lessons. 2023 May 22;5(21):CASE232. doi: 10.3171/CASE232. PMID: 37218733. Case report, Review. ˍ

Juratli TA, Jungk C, Miller JJ.
Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
J Neurooncol. 2023 May 22;162(3):457-459. doi: 10.1007/s11060-023-04317-3. PMID: 37212938. Review. ˍ

Bernhard C, Reita D, Martin S, Entz-Werle N, Dontenwill M.
Glioblastoma Metabolism: Insights and Therapeutic Strategies.
Int J Mol Sci. 2023 May 23;24(11):9137. doi: 10.3390/ijms24119137. PMID: 37298093. Review. ˍ

Solomou G, Finch A, Asghar A, Bardella C.
Mutant IDH in Gliomas: Role in Cancer and Treatment Options.
Cancers (Basel). 2023 May 23;15(11):2883. doi: 10.3390/cancers15112883. PMID: 37296846. Review. ˍ

Bianconi A, Palmieri G, Aruta G, Monticelli M, Zeppa P, Tartara F, Melcarne A, Garbossa D, Cofano F.
Updates in Glioblastoma Immunotherapy: An Overview of the Current Clinical and Translational Scenario.
Biomedicines. 2023 May 24;11(6):1520. doi: 10.3390/biomedicines11061520. PMID: 37371615. Review. ˍ

Sollmann N, Zhang H, Kloth C, Zimmer C, Wiestler B, Rosskopf J, Kreiser K, Schmitz B, Beer M, Krieg SM.
Modern preoperative imaging and functional mapping in patients with intracranial glioma.
Rofo. 2023 May 24. doi: 10.1055/a-2083-8717. PMID: 37224867. Review. ˍ

Yanchu L, Rong P, Rong C, Li Z, Xiaoyan Y, Feng W.
Ozone therapy for high-grade glioma: an overview.
Front Oncol. 2023 May 24;13:1161206. doi: 10.3389/fonc.2023.1161206. PMID: 37293584. Review. ˍ

Conarroe CA, Bullock TNJ. Ready for Prime Time?
Dendritic Cells in High-Grade Gliomas.
Cancers (Basel). 2023 May 25;15(11):2902. doi: 10.3390/cancers15112902. PMID: 37296865. Review. ˍ

Foster JB, Alonso MM, Sayour E, Davidson TB, Persson ML, Dun MD, Kline C, Mueller S, Vitanza NA, van der Lugt J.
Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.
Neoplasia. 2023 May 25;42:100909. doi: 10.1016/j.neo.2023.100909. PMID: 37244226. Review. ˍ

Lim J, Kang I, La J, Ku KB, Kang BH, Kim Y, Park WH, Lee HK.
Harnessing type I interferon-mediated immunity to target malignant brain tumors.
Front Immunol. 2023 May 25;14:1203929. doi: 10.3389/fimmu.2023.1203929. PMID: 37304294. Review. ˍ

Qiu Q, Ding X, Chen J, Chen S, Wang J.
Nanobiotechnology-based treatment strategies for malignant relapsed glioma.
J Control Release. 2023 May 25:S0168-3659(23)00329-2. doi: 10.1016/j.jconrel.2023.05.016. PMID: 37196900. Review˰ ˍ

Rodriguez A, Kamiya-Matsuoka C, Majd NK.
The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors.
Curr Oncol. 2023 May 25;30(6):5279-5298. doi: 10.3390/curroncol30060401. PMID: 37366884. Review. ˍ

Verso M, Muñoz A, Connors JM.
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive.
Intern Emerg Med. 2023 May 25. doi: 10.1007/s11739-023-03306-8. PMID: 37227679. Review˰ ˍ

Wang M, Wang X, Jin X, Zhou J, Zhang Y, Yang Y, Liu Y, Zhang J.
Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions.
Front Immunol. 2023 May 25;14:1175118. doi: 10.3389/fimmu.2023.1175118. PMID: 37304305. Review. ˍ

Borba LAB, Passos G, Oliveira I.
Liquid biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of patients diagnosed with central nervous system glioma - A review article.
Surg Neurol Int. 2023 May 26;14:183. doi: 10.25259/SNI_52_2023. PMID: 37292399. Review. ˍ

Lim-Fat MJ, Das S.
Unique molecular, clinical, and treatment aspects of gliomas in adolescents and young adults: a review.
J Neurosurg. 2023 May 26:1-9. doi: 10.3171/2023.4.JNS221800. PMID: 37243561. Review˰ ˍ

Webb MJ, Sener U, Vile RG.
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma.
Pharmaceuticals (Basel). 2023 May 26;16(6):793. doi: 10.3390/ph16060793. PMID: 37375742. Review. ˍ

Rao R, Patel A, Hanchate K, Robinson E, Edwards A, Shah S, Higgins D, Haworth KJ, Lucke-Wold B, Pomeranz Krummel D, Sengupta S.
Advances in Focused Ultrasound for the Treatment of Brain Tumors.
Tomography. 2023 May 29;9(3):1094-1109. doi: 10.3390/tomography9030090. PMID: 37368542. Review. ˍ

Ntenti C, Lallas K, Papazisis G.
Clinical, Histological, and Molecular Prognostic Factors in Childhood Medulloblastoma: Where Do We Stand?
Diagnostics (Basel). 2023 May 30;13(11):1915. doi: 10.3390/diagnostics13111915. PMID: 37296767. Review. ˍ

Rončević A, Koruga N, Soldo Koruga A, Rončević R, Rotim T, Šimundić T, Kretić D, Perić M, Turk T, Štimac D.
Personalized Treatment of Glioblastoma: Current State and Future Perspective.
Biomedicines. 2023 May 30;11(6):1579. doi: 10.3390/biomedicines11061579. PMID: 37371674. Review. ˍ

Scola E, Del Vecchio G, Busto G, Bianchi A, Desideri I, Gadda D, Mancini S, Carlesi E, Moretti M, Desideri I, Muscas G, Della Puppa A, Fainardi E.
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor.
Cancers (Basel). 2023 May 30;15(11):2992. doi: 10.3390/cancers15112992. PMID: 37296953. Review. ˍ

Kardani K, Sanchez Gil J, Rabkin SD.
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells.
Front Cell Infect Microbiol. 2023 May 31;13:1206111. doi: 10.3389/fcimb.2023.1206111. PMID: 37325516. Review. ˍ

Liu Y, Wu M.
Deep learning in precision medicine and focus on glioma.
Bioeng Transl Med. 2023 May 31;8(5):e10553
. doi: 10.1002/btm2.10553. PMID: 37693051. Review. ˍ

Shapiro JA, Gaonkar KS, Spielman SJ, Savonen CL, Bethell CJ, Jin R, Rathi KS, Zhu Y, Egolf LE, Farrow BK, Miller DP, Yang Y, Koganti T, Noureen N, Koptyra MP, Duong N, Santi M, Kim J, Robins S, Storm PB, Mack SC, Lilly JV, Xie HM, Jain P, Raman P, Rood BR, Lulla RR, Nazarian J, Kraya AA, Vaksman Z, Heath AP, Kline C, Scolaro L, Viaene AN, Huang X, Way GP, Foltz SM, Zhang B, Poetsch AR, Mueller S, Ennis BM, Prados M, Diskin SJ, Zheng S, Guo Y, Kannan S, Waanders AJ, Margol AS, Kim MC, Hanson D, Van Kuren N, Wong J, Kaufman RS, Coleman N, Blackden C, Cole KA, Mason JL, Madsen PJ, Koschmann CJ, Stewart DR, Wafula E, Brown MA, Resnick AC, Greene CS, Rokita JL, Taroni JN; Children’s Brain Tumor Network; Pacific Pediatric Neuro-Oncology Consortium.
OpenPBTA: The Open Pediatric Brain Tumor Atlas.
Cell Genom. 2023 May 31;3(7):100340. doi: 10.1016/j.xgen.2023.100340. PMID: 37492101. Tumor atlas. ˍ

Vallejo FA, Sigdel G, Veliz EA, Leblanc RM, Vanni S, Graham RM.
Carbon Dots in Treatment of Pediatric Brain Tumors: Past, Present, and Future Directions.
Int J Mol Sci. 2023 May 31;24(11):9562. doi: 10.3390/ijms24119562. PMID: 37298513. Review. ˍ

Zaidi SE, Moelker E, Singh K, Mohan A, Salgado MA, Essibayi MA, Hotchkiss K, Shen S, Lee W, Sampson J, Khasraw M.
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
BioDrugs. 2023 May 31. doi: 10.1007/s40259-023-00598-2. PMID: 37256535. Review˰ ˍ